← Open Payments lookup

TIMOTHY SSEWAGABA: Open Payments

NPI 1659613404 · PERTH AMBOY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$360 in 18 payments from 7 companies in 2025. Trend: 2023 $357 · 2024 $250 · 2025 $360

Food & beverage: $360
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$119
ABBVIE INC.5$100
Teva Pharmaceuticals USA, Inc.4$68
E.R. Squibb & Sons, L.L.C.1$26
Braeburn Inc.1$16
Otsuka America Pharmaceutical, Inc.1$16
Supernus Pharmaceuticals, Inc.1$15

Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, COBENFY, UZEDY, BRIXADI, REXULTI, Qelbree.

Industry payments across NJ — which companies pay providers there.